Methyldopa hydrate - CAS 41372-08-1

Methyldopa hydrate (MK-351 hydrate) is a DOPA decarboxylase inhibitor and indirect α2-adrenergic receptor agonist used to treat hypertension. It inhibits the sympathetic nervous system, decreases production of dopamine, norepinephrine, and epinephrine, and exhibits NO-dependent sedative activity.

Dopamine Receptor, Adrenergic Receptor, Endogenous Metabolite

Neuroscience, GPCR/G Protein, Metabolism

41372-08-1

0.9967

C10H13NO4·3/2H2O

238.24

O.C[C@](N)(Cc1ccc(O)c(O)c1)C(O)=O

-20°C

Ice Packs

Small Compound